Antibodies under a microscope

DHJ63105

Research Grade Mirikizumab

Description

LY-3074828, CAS: 1884201-71-1

Targets

SGRF, IL-23-A, IL-23 subunit alpha, Interleukin-23 subunit p19, IL23A, Interleukin-23 subunit alpha, IL-23p19

Isotype/Mimetic

IgG4-kappa

Animal-Derived Biomaterials Used

None

Sequence Available

No

Original Discovery Method

Unknown

Original Discovery Information Provided On Datasheet

No

Antibody/Binder Origins

Unknown discovery source/method, In vitro recombinant expression